{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:04:55Z","timestamp":1778263495401,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1245\/s10434-020-08922-8","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T17:02:43Z","timestamp":1595523763000},"page":"1521-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Radiographic Splenic Artery Involvement Is a Poor Prognostic Factor in Upfront Surgery for Patients with Resectable Pancreatic Body and Tail Cancer"],"prefix":"10.1245","volume":"28","author":[{"given":"Manabu","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Hirono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kitahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"8922_CR1","unstructured":"National Comprehensive Cancer Network. NCCN practice guidelines for pancreatic cancer, Version 1; 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/pancreatic.pdf."},{"key":"8922_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.surg.2005.08.004","volume":"139","author":"K Shimada","year":"2006","unstructured":"Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery 2006;139:288\u201395.","journal-title":"Surgery"},{"key":"8922_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/SLA.0b013e3181cf9171","volume":"251","author":"M Kanda","year":"2010","unstructured":"Kanda M, Fujii T, Sahin TT, et al. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas. Ann Surg. 2010;251:483\u20137.","journal-title":"Ann Surg."},{"key":"8922_CR4","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1245\/s10434-011-1769-1","volume":"18","author":"S Partelli","year":"2011","unstructured":"Partelli S, Crippa S, Barugola G, et al. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Ann Surg Oncol. 2011;18:3608\u201314.","journal-title":"Ann Surg Oncol."},{"key":"8922_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijsu.2016.09.076","volume":"35","author":"Y Fukami","year":"2016","unstructured":"Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Onoe S. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail. Int J Surg. 2016;35:64\u20138.","journal-title":"Int J Surg."},{"key":"8922_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1245\/s10434-017-6274-8","volume":"25","author":"T Mizumoto","year":"2018","unstructured":"Mizumoto, T, Toyama H, Asari S, et al. Pathological and radiological splenic vein involvement are predictors of poor prognosis and early liver metastasis after surgery in patients with pancreatic adenocarcinoma of the body and tail. Ann Surg Oncol. 2018;25:638\u201346.","journal-title":"Ann Surg Oncol."},{"key":"8922_CR7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jso.25498","volume":"120","author":"JJ Hyun","year":"2019","unstructured":"Hyun JJ,\u00a0Rose JB,\u00a0Alseidi AA,\u00a0et al. Significance\u00a0of\u00a0radiographic\u00a0splenic\u00a0vessel\u00a0involvement\u00a0in the pancreatic ductal adenocarcinoma of the body and tail of the gland. J Surg Oncol.\u00a02019;120:262\u20139.","journal-title":"J Surg Oncol."},{"key":"8922_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1067\/msy.2003.146","volume":"133","author":"SM Strasberg","year":"2003","unstructured":"Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521\u20137.","journal-title":"Surgery."},{"key":"8922_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.sla.0000258608.52615.5a","volume":"246","author":"S Hirano","year":"2007","unstructured":"Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007;246:46\u201351.","journal-title":"Ann Surg."},{"key":"8922_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.surg.2012.07.036","volume":"153","author":"K Okada","year":"2013","unstructured":"Okada K, Kawai M, Tani M, et al. Surgical strategy for patients with pancreatic body\/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 2013;153:365\u2013372.","journal-title":"Surgery"},{"key":"8922_CR11","volume-title":"TNM Classification of Malignant Tumours","author":"James D Brierley","year":"2017","unstructured":"James D. Brierley, Mary K. Gospodarowicz, Christian Wittekind. TNM classification of malignant tumours. 8th ed. Hoboken: Wiley-Blackwell; 2017.","edition":"8"},{"key":"8922_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/SLA.0000000000001731","volume":"265","author":"O Strobel","year":"2017","unstructured":"Strobel O,\u00a0Hank T,\u00a0Hinz U,\u00a0et al. Pancreatic cancer\u00a0surgery: the new R-status\u00a0counts. Ann Surg.\u00a02017;265:565\u2013573.","journal-title":"Ann Surg."},{"key":"8922_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u2013213.","journal-title":"Ann Surg."},{"key":"8922_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11\u00a0years after. Surgery 2017;161:584\u201391.","journal-title":"Surgery"},{"key":"8922_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.surg.2007.05.005","volume":"142","author":"MN Wente","year":"2007","unstructured":"Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761\u2013768.","journal-title":"Surgery"},{"key":"8922_CR16","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1097\/MPA.0000000000000634","volume":"45","author":"S Hirono","year":"2016","unstructured":"Hirono S, Kawai M, Okada KI, et al. treatment strategy for borderline resectable pancreatic cancer with radiographic artery involvement. Pancreas 2016;45:1438\u20131446.","journal-title":"Pancreas"},{"key":"8922_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-013-2323-6","volume":"73","author":"H Yamaue","year":"2014","unstructured":"Yamaue H, Satoi S, Kanbe T, et al. Phase II clinical study of alternate-day oral therapywithS-1 as first-line chemotherapy for locally-advanced and metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2014;73:97\u2013102.","journal-title":"Cancer Chemother Pharmacol."},{"key":"8922_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00280-016-3121-8","volume":"78","author":"KI Okada","year":"2016","unstructured":"Okada KI, Kawai M, Hirono S, et al. Impact of treatment duration of neoadjuvant FIRINOX in patients with borderline resectable pancreatic cancer: a pilot trial. Cancer Chemother Pharmacol. 2016;78:719\u201326.","journal-title":"Cancer Chemother Pharmacol."},{"key":"8922_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.21873\/anticanres.11389","volume":"37","author":"KI Okada","year":"2017","unstructured":"Okada KI, Hirono S, Kawai M, et al. Phase I study of nab-paclitaxel plus gemcitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. Anticancer Res. 2017;37:853\u2013858.","journal-title":"Anticancer Res."},{"key":"8922_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected\u00a0pancreatic cancer: the\u00a0CONKO-001 randomized trial. JAMA. 2013;310:1473\u201381.","journal-title":"JAMA."},{"key":"8922_CR21","doi-asserted-by":"crossref","unstructured":"Uesaka K, Boku N, Fukutomi A, et al; JASPAC 01 Study Group. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388:248\u201357.","DOI":"10.1016\/S0140-6736(16)30583-9"},{"key":"8922_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.20440","volume":"93","author":"M Tani","year":"2006","unstructured":"Tani\u00a0M,\u00a0Kawai\u00a0M, Terasawa H, et al. Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer? J Surg Oncol. 2006;93:485\u201390.","journal-title":"J Surg Oncol."},{"key":"8922_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.surg.2014.09.022","volume":"157","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Akita H, Gotoh K, et al. Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on operative outcome and pattern of recurrence. Surgery. 2015;157:484\u201395.","journal-title":"Surgery."},{"key":"8922_CR24","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00432-014-1728-x","volume":"140","author":"R Yang","year":"2014","unstructured":"Yang R, Lu M, Qian X, et al. Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review. J Cancer Res Clin Oncol. 2014;140: 2077\u201386.","journal-title":"J Cancer Res Clin Oncol."},{"key":"8922_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/PAS.0b013e318065bfe6","volume":"31","author":"S Mitsunaga","year":"2007","unstructured":"Mitsunaga S,\u00a0Hasebe T,\u00a0Kinoshita T,\u00a0et al. Detail histologic analysis of nerve plexus\u00a0invasion\u00a0in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol.\u00a02007;31:1636\u201344.","journal-title":"Am J Surg Pathol."},{"key":"8922_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MPA.0b013e31818166e6","volume":"37","author":"I Makino","year":"2008","unstructured":"Makino I, Kitagawa H, Ohta T,\u00a0et al. Nerve\u00a0plexus\u00a0invasion\u00a0in\u00a0pancreatic cancer:\u00a0spread\u00a0patterns\u00a0on histopathologic and embryological analyses. Pancreas\u00a02008;37:358\u201365.","journal-title":"Pancreas"},{"key":"8922_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/MPA.0b013e31820b5d37","volume":"40","author":"K Shimada","year":"2011","unstructured":"Shimada K,\u00a0Nara S,\u00a0Esaki M,\u00a0Sakamoto Y,\u00a0Kosuge T,\u00a0Hiraoka N. Intrapancreatic nerve\u00a0invasion\u00a0as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas\u00a02011;40:464\u20138.","journal-title":"Pancreas"},{"key":"8922_CR28","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","volume":"74","author":"RE Stopczynski","year":"2014","unstructured":"Stopczynski RE, Normolle DP, Hartman DJ, et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Res. 2014;74:1718\u201327.","journal-title":"Cancer Res."},{"key":"8922_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrc.2016.38","volume":"16","author":"M Amit","year":"2016","unstructured":"Amit M, Na\u2019ara S, Gil Z. Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016;16:399\u2013408.","journal-title":"Nat Rev Cancer."},{"key":"8922_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02924114","volume":"10","author":"T Nagakawa","year":"1991","unstructured":"Nagakawa T, Kayahara M, Ohta T, et al. Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol. 1991;10:113\u2013119.","journal-title":"Int J Pancreatol."},{"key":"8922_CR31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/bjs.1800830810","volume":"83","author":"JM Fabre","year":"1996","unstructured":"Fabre JM, Houry S, Manderscheid JC, et al. Surgery for left-sided pancreatic cancer. Br J Surg. 1996;83:1065\u20131070.","journal-title":"Br J Surg."},{"key":"8922_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/SLA.0000000000002705","volume":"268","author":"JY Jang","year":"2018","unstructured":"Jang JY, Han Y, Lee H, et al. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2\/3 trial. Ann Surg. 2018;268:215\u201322.","journal-title":"Ann Surg."},{"key":"8922_CR33","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1245\/s10434-014-4225-1","volume":"22","author":"M Blazer","year":"2015","unstructured":"Blazer M, Wu C, Goldberg RM, et al. Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas. Ann Surg Oncol. 2015;22:1153\u20139.","journal-title":"Ann Surg Oncol."},{"key":"8922_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00280-016-3199-z","volume":"79","author":"Y Murakami","year":"2017","unstructured":"Murakami Y, Uemura K, Sudo T, et al. Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact. Cancer Chemother Pharmacol. 2017;79:37\u201347.","journal-title":"Cancer Chemother Pharmacol."},{"key":"8922_CR35","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1245\/s10434-019-07735-8","volume":"26","author":"H Eguchi","year":"2019","unstructured":"Eguchi H,\u00a0Takeda Y,\u00a0Takahashi H,\u00a0et al. A\u00a0prospective,\u00a0open-label,\u00a0multicenter\u00a0phase\u00a02\u00a0trial\u00a0of\u00a0neoadjuvant\u00a0therapy\u00a0using\u00a0full-dose\u00a0gemcitabine\u00a0and\u00a0s-1\u00a0concurrent\u00a0with\u00a0radiation\u00a0for\u00a0resectable\u00a0pancreatic\u00a0ductal\u00a0adenocarcinoma. Ann Surg Oncol.\u00a02019;26:4498\u20134505.","journal-title":"Ann Surg Oncol."},{"key":"8922_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S2468-1253(18)30081-5","volume":"3","author":"M Reni","year":"2018","unstructured":"Reni M,\u00a0Balzano G,\u00a0Zanon S,\u00a0et al. Safty\u00a0and\u00a0efficacy\u00a0of\u00a0preoperative\u00a0or\u00a0postoperative\u00a0chemotherapy\u00a0for\u00a0resectable pancreatic\u00a0adenocarcinoma (PACT-15): a randomised, open-label, phase 2\u20133 trial. Lancet Gastroenterol Hepatol.\u00a02018;3:413\u2013423.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8922_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.surg.2016.08.040","volume":"161","author":"SW de Geus","year":"2017","unstructured":"de Geus SW,\u00a0Eskander MF,\u00a0Bliss LA,\u00a0et al. Neoadjuvant therapy\u00a0versus\u00a0upfront\u00a0surgery for resected\u00a0pancreatic\u00a0adenocarcinoma: A nationwide\u00a0propensity score\u00a0matched\u00a0analysis. Surgery\u00a02017;161:592\u2013601.","journal-title":"Surgery"},{"key":"8922_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1200\/JCO.2016.68.5081","volume":"35","author":"AA Mokdad","year":"2017","unstructured":"Mokdad AA,\u00a0Minter RM,\u00a0Zhu H,\u00a0et al. Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis. J Clin Oncol 2017;35:515\u201322.","journal-title":"J Clin Oncol"},{"key":"8922_CR39","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1245\/s10434-018-6765-2","volume":"25","author":"DW Nelson","year":"2018","unstructured":"Nelson DW, Chang SC, Grunkemeier G, et al. Resectable\u00a0distal\u00a0pancreas cancer: time to reconsider the role of upfront surgery. Ann Surg Oncol 2018;25:4012\u20134019.","journal-title":"Ann Surg Oncol"},{"key":"8922_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejso.2017.10.217","volume":"44","author":"S Crippa","year":"2018","unstructured":"Crippa S, Cirocchi R, Maisonneuve P, et al. Systematic review\u00a0and\u00a0meta-analysis\u00a0of\u00a0prognostic\u00a0role\u00a0of\u00a0splenic\u00a0vessels infiltration in resectable pancreatic cancer. Eur J Surg Oncol 2018;44:24\u201330.","journal-title":"Eur J Surg Oncol"},{"key":"8922_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/SLA.0000000000002781","volume":"270","author":"G Malleo","year":"2019","unstructured":"Malleo G,\u00a0Maggino L,\u00a0Ferrone CR, et al. Number of examined\u00a0lymph nodes\u00a0and nodal status assessment in distal pancreatectomy for body\/tail ductal adenocarcinoma. Ann Surg.\u00a02019;270:1138\u20131146.","journal-title":"Ann Surg."},{"key":"8922_CR42","doi-asserted-by":"crossref","unstructured":"Asano D, Nara S, Kishi Y,\u00a0et al. A single-institution validation study of\u00a0lymph\u00a0node staging by the AJCC 8th edition for patients with\u00a0pancreatic\u00a0head\u00a0cancer: a proposal to subdivide the N2 category. Ann Surg Oncol. 2019;26:2112\u201320.","DOI":"10.1245\/s10434-019-07390-z"},{"key":"8922_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.04.006","author":"G Malleo","year":"2020","unstructured":"Malleo G,\u00a0Maggino L,\u00a0Nobile S, et al. Reappraisal of nodal staging and study of\u00a0lymph node\u00a0station involvement in distal pancreatectomy for body-tail\u00a0pancreatic\u00a0ductal adenocarcinoma. Eur J Surg Oncol.\u00a02020. https:\/\/doi.org\/10.1016\/j.ejso.2020.04.006.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08922-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:48:23Z","timestamp":1696445303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08922-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["8922"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08922-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"11 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}